↓ Skip to main content

Cochrane Database of Systematic Reviews

Beta blockers for peripheral arterial disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
66 Mendeley
citeulike
1 CiteULike
Title
Beta blockers for peripheral arterial disease
Published in
Cochrane database of systematic reviews, September 2013
DOI 10.1002/14651858.cd005508.pub3
Pubmed ID
Authors

Sharath Chandra Vikram Paravastu, Derick A Mendonca, Anthony Da Silva

Abstract

Beta (β) blockers are indicated for use in coronary artery disease (CAD). However, optimal therapy for people with CAD accompanied by intermittent claudication has been controversial because of the presumed peripheral haemodynamic consequences of beta blockers, leading to worsening symptoms of intermittent claudication. This is an update of a review first published in 2008.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Canada 1 2%
Unknown 64 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 18%
Student > Master 9 14%
Student > Ph. D. Student 8 12%
Student > Bachelor 6 9%
Other 4 6%
Other 15 23%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 25 38%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Nursing and Health Professions 5 8%
Agricultural and Biological Sciences 4 6%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 6 9%
Unknown 17 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#9,566,889
of 17,353,889 outputs
Outputs from Cochrane database of systematic reviews
#9,150
of 11,661 outputs
Outputs of similar age
#63,435
of 139,302 outputs
Outputs of similar age from Cochrane database of systematic reviews
#81
of 116 outputs
Altmetric has tracked 17,353,889 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,661 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,302 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.